SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL

SEROPREVALENCE OF TOXOPLASMA GONDII INFECTION AND ITS ASSOCIATED RISK FACTORS IN NEUROPSYCHIATRIC PATIENTS IN JAZAN PROVINCE, SAUDI ARABIA

TOXOPLASMOSIS AMONG SCHIZOPHRENIC PATIENTS

TOXOPLASMOSIS AND RISK OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND MAJOR DEPRESSIVE DISORDER: A REVIEW ARTICLE

SERO-PREVALENCE OF TOXOPLASMA GONDII IN SMALL RUMINANTS

SEROPREVALENCE OF TOXOPLASMA GONDII INFECTION AND ASSOCIATED RISK FACTORS AMONG ASYMPTOMATIC PREGNANT FEMALES IN EGYPT

Investigation of the possible relation between seropositivity to anti-Toxoplasma immunoglobulin-G, peripheral dopamine, cortisol, and oxidative stress in Egyptian schizophrenic p

SEROPREVALENCE OF TOXOPLAMA GONDII AMONG PRIMIGRAVIDA WOMEN AND THEIR NEONATES IN SOHAG GOVERNORATE, EGYPT

Toxoplasma gondii seroprevalence among women of childbearing age referred to clinical laboratories in Ilam, Western Iran

PREVALENCE AND RISK FACTORS OF TOXOPLASMOSIS AMONG WOMEN OF REPRODUCTIVE AGE, SOUTHWESTERN IRAN